dorsaVi (ASX:DVL) appointed Mathew Regan as group chief executive, effective Nov. 1, according to a Thursday Australian bourse filing.
Regan previously served as CEO of Artrya (ASX:AYA), per the filing.
Andrew Ronchi will continue as CEO of the company's sensor division, the filing added.
dorsaVi's shares rose past 2% in recent Thursday trade, while Artrya's shares fell 4%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.